Skip to main content

Table 3 Adverse events in both pediatric and adult patients

From: A pilot study of safety of sulfamethoxazole, trimethoprim and guaifenesin in pediatric and adult patients with acute bronchitis

Characteristics

Pediatric patients

Adult patients

n

%

n

%

Adverse events

Yes

5

9.6

10

19.2

No

46

88.4

42

80.8

Causality

Definite

0

_

2

20

Possible

4

80

2

20

Probable

0

_

4

40

Unlikely

1

20

2

20

None

0

_

0

_

Outcome of adverse event

Total recovery

4

80

7

70

Recoveringa

1

20

2

20

Recovery with sequelae

0

_

0

_

Without recoverya

0

_

1

10

Fatal

0

_

0

_

  1. aAssessed at the last day of follow-up (day 10th)